BIO.News Newsletter

Today, President Biden will sign important legislation addressing anti-Asian hate crimes. We applaud the law’s passage—and the important contributions of the AAPI community to innovation. Also, two of the best science communicators we know tells us more about the “bio-revolution,” and we recap yesterday's HHS appropriations hearing. (1078 words, 5 minutes, 23 seconds)

Everyone’s talking about COVID vaccine equity—but what should we REALLY do to make it happen? We joined a commitment outlining five concrete steps. Meanwhile, we tell you what you need to watch in D.C. today and how you can support farmers and the planet. (762 words, 3 minutes, 48 seconds)

The U.S. will donate an additional 20 million COVID vaccine doses to countries in need—read Dr. Michelle's response. Meanwhile, it's HIV Vaccine Awareness Day and we look at how COVID brought us one step closer to success, as well as DOE's new funding to advance biofuels and reduce carbon. (832 words, 4 minutes, 9 seconds)

Starting a new week with the latest news on the TRIPS waiver—including what Members of Congress said about it—plus a look at bioengineered fashion and a busy Monday on the Hill. (832 words, 4 minutes, 9 seconds)

A recap of this week’s hearings on the Biden administration’s trade policy agenda, words of wisdom from Dr. Michelle on how to address vaccine hesitancy among communities of color, and a lot of news. (960 words, 4 minutes, 40 seconds)

We have details on a new study about who really funds FDA-approved medicines, and a bill making its way through the Senate that would boost R&D and the bioeconomy. We’re also watching a House Ways & Means Committee hearing with USTR; we’ll have more on that tomorrow. (716 words, 3 minutes, 34 seconds)

Ahead of congressional hearings today and tomorrow on the Biden administration’s trade policy agenda, we’re unpacking two critical global trade issues: IP protections for COVID-19 vaccines and Mexico’s response to gene-edited agricultural products, specifically corn. (892 words, 4 minutes, 27 seconds)

Today’s all about the kids. The FDA authorized the use of Pfizer’s vaccine in younger teens, and Amyris announced a new partnership to help families and babies in need stay safe during the pandemic. Here’s what you need to know—plus how you can help. (698 words, 3 minutes, 29 seconds)

Starting a new week with a discussion on why diversity has been lacking in clinical trials—and what the industry can do about it. Listen to the latest episode of the I AM BIO Podcast or keep reading. We also have sweet news for plastic pollution and news on a historic nominee at USDA. (712 words, 3 minutes, 33 seconds)

Ending the week with a lot of promising news out of Europe. Germany’s not in favor of a waiver on vaccine patents—and the EU is still deciding. Meanwhile, it looks like the tide could be turning when it comes to gene editing in Europe. (662 words, 3 minutes, 18 seconds)